Cytokinetics Inc (CYTK): Cash & Equivalents
$122.52M
As of 2025-12-31
$255.27M
As of 2026-06-30
+23.2%
3-year compound annual growth
+8.1%
5-year compound annual growth
+6.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $122.52M | +29.2% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $94.86M | -16.1% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $113.02M | +72.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $65.58M | -41.8% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $112.67M | +35.8% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $82.98M | +127.8% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $36.43M | -13.8% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $42.26M | -66.3% | 2020-03-04, Balance as of period end |
| 2017-12-31 | $125.21M | +87.2% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $66.87M | +2.8% | 2018-03-05, Balance as of period end |
| 2015-12-31 | $65.08M | +221.9% | 2018-03-05, Balance as of period end |
| 2014-12-31 | $20.21M | +0.3% | 2017-03-06, Balance as of period end |
| 2013-12-31 | $20.16M | +35.2% | 2016-03-03, Balance as of period end |
| 2012-12-31 | $14.91M | -20.8% | 2015-03-06, Balance as of period end |
| 2011-12-31 | $18.83M | +7.5% | 2014-03-07, Balance as of period end |
| 2010-12-31 | $17.51M | -31.5% | 2013-03-15, Balance as of period end |
| 2009-12-31 | $25.56M | -38.9% | 2013-03-15, Balance as of period end |
| 2008-12-31 | $41.82M | n/a | 2012-03-13, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | $122.52M | +29.2% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $120.86M | -27.5% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $41.32M | -18.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $246.96M | +124.5% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $230.91M | -2.6% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $154.97M | -0.3% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $261.34M | +4.2% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $25.94M | +73.7% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $12.67M | -66.7% |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗